Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416659 · ClinicalTrials.gov registry record
Flow Arrest Safety and Technical Success With Balloon Guide Catheters
A clinical trial, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- 52
- Enrollment target
NCT04416659 is a clinical trial that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 52 participants.
The verdict
NCT04416659 has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The objective of this post-market registry is to assess technical efficacy and safety associated with the use of the BOSS Balloon Guide Catheter during neuro-vascular procedures while providing temporary arrest of blood flow.
Interventions
- DEVICE Neuro-vascular access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-01-12 |
| Est. Completion | 2021-10-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04416659
The ClinicalTrials.gov registry entry for NCT04416659 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neuro-vascular access is the first listed.
NCT04416659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04416659 about?
NCT04416659 is a clinical study titled "Flow Arrest Safety and Technical Success With Balloon Guide Catheters". The objective of this post-market registry is to assess technical efficacy and safety associated with the use of the BOSS Balloon Guide Catheter during neuro-vascular procedures while providing temporary arrest of blood flow.
What is the current status of trial NCT04416659?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2021-01-12. Estimated completion is 2021-10-27.
What interventions are being tested in trial NCT04416659?
The interventions under investigation include: Neuro-vascular access (DEVICE).
Who is sponsoring clinical trial NCT04416659?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.